A. M. Monro

3.2k total citations · 1 hit paper
63 papers, 2.2k citations indexed

About

A. M. Monro is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Organic Chemistry. According to data from OpenAlex, A. M. Monro has authored 63 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Health, Toxicology and Mutagenesis, 14 papers in Cancer Research and 13 papers in Organic Chemistry. Recurrent topics in A. M. Monro's work include Carcinogens and Genotoxicity Assessment (14 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). A. M. Monro is often cited by papers focused on Carcinogens and Genotoxicity Assessment (14 papers), Effects and risks of endocrine disrupting chemicals (8 papers) and Drug Transport and Resistance Mechanisms (8 papers). A. M. Monro collaborates with scholars based in United States, United Kingdom and France. A. M. Monro's co-authors include Harry M. Olson, Graham R. Betton, Karluss Thomas, William M. Bracken, Allen H. Heller, Peter J. Smith, Bruce M. Berger, Michael A. Dorato, Patrick D. Lilly and Gerald J. Kolaja and has published in prestigious journals such as Science, JNCI Journal of the National Cancer Institute and Analytical Biochemistry.

In The Last Decade

A. M. Monro

63 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals

2000 1.4k citations Harry M. Olson, Graham R. Betton et al. Regulatory Toxicology and Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. M. Monro United States	20	503	497	303	268	265	63	2.2k
Harry M. Olson United States	9	480 1.0×	452 0.9×	249 0.8×	268 1.0×	270 1.0×	16	2.0k
Gerald J. Kolaja United States	10	397 0.8×	474 1.0×	230 0.8×	255 1.0×	241 0.9×	16	1.6k
Allen H. Heller United States	21	582 1.2×	494 1.0×	243 0.8×	265 1.0×	286 1.1×	48	2.5k
Bruce M. Berger United States	5	369 0.7×	449 0.9×	227 0.7×	253 0.9×	242 0.9×	9	1.6k
Ruben de Kanter Switzerland	23	724 1.4×	1.0k 2.1×	87 0.3×	310 1.2×	148 0.6×	41	2.7k
Fabrice Morel France	32	1.7k 3.3×	1.2k 2.4×	76 0.3×	250 0.9×	127 0.5×	51	3.6k
Yves Berger United States	28	564 1.1×	676 1.4×	80 0.3×	92 0.3×	97 0.4×	80	2.8k
Shelli Schomaker United States	15	481 1.0×	670 1.3×	54 0.2×	63 0.2×	65 0.2×	25	1.9k
Donna A. Volpe United States	26	588 1.2×	286 0.6×	88 0.3×	192 0.7×	138 0.5×	62	2.4k
Alfred Tonelli United States	12	477 0.9×	251 0.5×	163 0.5×	131 0.5×	61 0.2×	25	2.0k

Countries citing papers authored by A. M. Monro

Since Specialization

Citations

This map shows the geographic impact of A. M. Monro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. M. Monro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. M. Monro more than expected).

Fields of papers citing papers by A. M. Monro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. M. Monro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. M. Monro. The network helps show where A. M. Monro may publish in the future.

Co-authorship network of co-authors of A. M. Monro

This figure shows the co-authorship network connecting the top 25 collaborators of A. M. Monro. A scholar is included among the top collaborators of A. M. Monro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. M. Monro. A. M. Monro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Monro, A. M.. (2001). Toxicologists – come out and educate!. Trends in Pharmacological Sciences. 22(6). 325–327. 5 indexed citations

Davies, Teifion, Barry Lynch, A. M. Monro, I.C. Munro, & Earle R. Nestmann. (2000). Rodent carcinogenicity tests need be no longer than 18 months: an analysis based on 210 chemicals in the IARC Monographs. Food and Chemical Toxicology. 38(2-3). 219–235. 23 indexed citations

Olson, Harry M., Graham R. Betton, Denise E. Robinson, et al.. (2000). Concordance of the Toxicity of Pharmaceuticals in Humans and in Animals. Regulatory Toxicology and Pharmacology. 32(1). 56–67. 1417 indexed citations breakdown →

Monro, A. M., et al.. (1998). Veterinary Drugs No Longer Need Testing for Carcinogenicity in Rodent Bioassays. Regulatory Toxicology and Pharmacology. 28(2). 115–123. 5 indexed citations

Monro, A. M. & J. S. Macdonald. (1998). Evaluation of the Carcinogenic Potential of Pharmaceuticals. Drug Safety. 18(5). 309–319. 16 indexed citations

Monro, A. M., et al.. (1996). Are single-dose toxicology studies in animals adequate to support single doses of a new drug in humans?. Clinical Pharmacology & Therapeutics. 59(3). 258–264. 10 indexed citations

Monro, A. M., et al.. (1996). The safety assessment of drug residues at injection sites. Journal of Veterinary Pharmacology and Therapeutics. 19(4). 312–312. 4 indexed citations

Davies, Thomas S. & A. M. Monro. (1995). The case for an upper dose limit of 1000 mg/kg in rodent carcinogenicity tests. Cancer Letters. 95(1-2). 69–77. 1 indexed citations

Davies, Thomas S. & A. M. Monro. (1995). Marketed Human Pharmaceuticals Reported to be Tumorigenic in Rodents. Journal of the American College of Toxicology. 14(2). 90–107. 45 indexed citations

10.

Davies, Teifion & A. M. Monro. (1994). The Rodent Carcinogenicity Bioassay Produces a Similar Frequency of Tumor Increases and Decreases: Implications for Risk Assessment. Regulatory Toxicology and Pharmacology. 20(3). 281–301. 20 indexed citations

11.

Monro, A. M.. (1994). Drug toxicokinetics: scope and limitations that arise from species differences in pharmacodynamic and carcinogenic responses. Journal of Pharmacokinetics and Biopharmaceutics. 22(1). 41–57. 10 indexed citations

12.

Paulus, G., et al.. (1994). Human carcinogenic risk assessment based on hormonal effects in a carcinogenicity study in rats with the antifungal agent, fluconazole. Teratogenesis Carcinogenesis and Mutagenesis. 14(6). 251–257. 4 indexed citations

13.

Monro, A. M. & Thomas S. Davies. (1993). High dose levels are not necessary in rodent studies to detect human carcinogens. Cancer Letters. 75(3). 183–194. 11 indexed citations

14.

Charuel, Claude, Pierre Comby, & A. M. Monro. (1992). Diurnal exposure profile in rats from dietary administration of a chemical (doxazosin) with a short half‐life: Interplay of age and diurnal feeding pattern. Journal of Applied Toxicology. 12(1). 7–11. 5 indexed citations

15.

Monro, A. M.. (1990). Interspecies comparisons in toxicology: The utility and futility of plasma concentrations of the test substance. Regulatory Toxicology and Pharmacology. 12(2). 137–160. 25 indexed citations

16.

Monro, A. M., et al.. (1990). A rapidly reversible effect of a single dose of phenoxybenzamine on the fertility of male rats. Toxicology Letters. 52(2). 221–224. 2 indexed citations

17.

Greaves, Peter, et al.. (1987). A cytochemical study of the livers of rats treated with diethylnitrosamine/phenobarbital, with benzidine/phenobarbital, with phenobarbital, or with clofibrate. Toxicology. 46(2). 217–236. 5 indexed citations

18.

Stadler, Jeanne, et al.. (1987). Effects of tioconazole on parturition and serum levels of 17β-oestradiol, progesterone, LH and PRL in the rat. Biochemical Pharmacology. 36(7). 1119–1124. 3 indexed citations

19.

Marriott, M. S., K. W. Brammer, J. M. Faccini, et al.. (1983). Tioconazole, a New Broad-Spectrum Antifungal Agent: Preclinical Studies Related to Vaginal Candidiasis. Gyn�kologisch-geburtshilfliche Rundschau. 23(1). 1–11. 5 indexed citations

20.

Monro, A. M., et al.. (1972). Potential errors in liquid scintillation counting of very dilute solutions of labeled tetracyclines. Analytical Biochemistry. 47(1). 73–79. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact